Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Gnosis by Lesaffre.

    Client Virtual Booth

    GNOSIS BY LESAFFRE

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Gnosis by Lesaffre
    France Flag
    Country
    Country
    France
    Address
    Address
    137 rue Gabriel Péri 59700 Marcq-en-Baroeul France
    Telephone
    Telephone
    +33 (0)3 20 81 61 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://gnosisbylesaffre.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/gnosis-by-lesaffre/
    Twitter
    Twitter
    https://twitter.com/gnosislesaffre

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    left grey arrow
    right gray arrow
    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient

    Details:

    The partnership aims to launch SunWay's inaugural product, MenaQ7® Metabolic, featuring two key active ingredients, MenaQ7® Vitamin K2 as MK-7 and ANKASCIN® 568-R.


    Lead Product(s): Menaquinone-7,Ankascin 568-R

    Therapeutic Area: Cardiology/Vascular Diseases Product Name: MenaQ7

    Highest Development Status: ApprovedProduct Type: Small molecule

    Recipient: SunWay Biotech

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership March 14, 2024

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Gnosis by Lesaffre Enhances Vitamin K2 Offering with Acquisition of NattoPharma

    Details:

    This acquisition brings together globally recognized vitamin K2 brands vitaMK7® and MenaQ7® and allows Gnosis by Lesaffre to offer to the market the most complete portfolio of solutions, adapted to each market need and able to satisfy all customers.


    Lead Product(s): Vitamin K2

    Therapeutic Area: Musculoskeletal Product Name: MenaQ7

    Highest Development Status: ApprovedProduct Type: Small molecule

    Recipient: NattoPharma

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Acquisition May 25, 2021

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-05-06

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search